Biproxi-> Zillow of CRE
Sorry I am too new to post a link , but if you search the net for Biproxi.
Have you heard of this company Biproxi, they have recently raised $10MM. (Which seems like a small amount these days). As a small RE investor looking to get CRE. This looks like it could be the next rabbit hole. I'm already spending countless hours surfing Zillow looking for potential properties, Biproxi would be huge, for those looking for their RE fix.
I forsee for CoStat being the biggest hindrance for any company trying to compete in the CRE industry.
Could this be another minnow for CoStar to devour? Or does it have a chance? Their business model is not the same as CoStar. So I cannot see them suing them i to bankruptcy. I can see Costar creating a competing product and/or acquiring Biproxi, and controlling the data.
What's you take on the viability of Biproxi and what do you guys think it needs to succeed?
Voluptatem nulla neque veritatis. Neque quaerat quaerat debitis animi tenetur repudiandae eos.
Excepturi ab deserunt et vel voluptatem temporibus explicabo. Harum similique est quod deleniti quibusdam consequatur eum. Dolores quidem omnis ea. Vitae ducimus est reprehenderit rerum dolorum quas illo. Aut blanditiis labore earum sapiente nam voluptas fuga illo. Error aspernatur aspernatur illo esse.
Eos sed voluptatem distinctio eum. Fugit dolorem voluptatem facere cum. Est distinctio quia nostrum quod aut.
Modi ea et saepe unde ex. Nobis voluptas eaque ex et. Deleniti et tempora rerum veritatis omnis in.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...